These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6135100)

  • 1. Bactericidal intraprostatic concentrations of norfloxacin.
    Bologna M; Vaggi L; Forchetti CM; Martini E
    Lancet; 1983 Jul; 2(8344):280. PubMed ID: 6135100
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prostatic concentrations of norfloxacin using HPLC].
    Bologna M; Cavicchio GC; Forchetti CM; Rucci A; Di Nicola G; Vaggi L
    G Ital Chemioter; 1984; 31(1-2):59-63. PubMed ID: 6236124
    [No Abstract]   [Full Text] [Related]  

  • 3. Improved high-performance liquid chromatographic determination of pefloxacin and its metabolite norfloxacin in human plasma and tissue.
    Montay G; Tassel JP
    J Chromatogr; 1985 Apr; 339(1):214-8. PubMed ID: 3160717
    [No Abstract]   [Full Text] [Related]  

  • 4. [Norfloxacin treatment of acute cystitis in the female and bacterial prostatitis].
    Bischoff W
    Fortschr Med; 1985 Feb; 103(8):225-8. PubMed ID: 3156797
    [No Abstract]   [Full Text] [Related]  

  • 5. Potential usefulness of norfloxacin in the treatment of urinary tract infections.
    Norrby SR
    Eur J Clin Microbiol; 1983 Jun; 2(3):227-9. PubMed ID: 6224677
    [No Abstract]   [Full Text] [Related]  

  • 6. Determination of norfloxacin, a new nalidixic acid analog, in human serum and urine by high-performance liquid chromatography.
    Boppana VK; Swanson BN
    Antimicrob Agents Chemother; 1982 May; 21(5):808-10. PubMed ID: 6213199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-performance liquid chromatographic procedure for the quantitation of norfloxacin in urine, serum and tissues.
    Forchetti C; Flammini D; Carlucci G; Cavicchio G; Vaggi L; Bologna M
    J Chromatogr; 1984 Jul; 309(1):177-82. PubMed ID: 6237115
    [No Abstract]   [Full Text] [Related]  

  • 8. Distribution of quinoline carboxylic acid derivatives in the dog prostate.
    Jensen KM; Madsen PO
    Prostate; 1983; 4(4):407-14. PubMed ID: 6223287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Norfloxacin (MK-0366) treatment of urinary tract infections in hospitalized patients.
    Panichi G; Pantosti A; Testore GP
    J Antimicrob Chemother; 1983 Jun; 11(6):589-92. PubMed ID: 6224769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraprostatic bactericidal concentrations of Norfloxacin.
    Denis B; Wauters G; Wese F; Van Cangh PJ
    Acta Urol Belg; 1986; 54(3):348-52. PubMed ID: 3776761
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of urinary tract infections].
    Borsa F; Humbert G
    Rev Prat; 1985 Mar; 35(15):843-51. PubMed ID: 3159070
    [No Abstract]   [Full Text] [Related]  

  • 12. Norfloxacin--a new quinolone for urinary infection.
    J Antimicrob Chemother; 1984 May; 13 Suppl B():1-142. PubMed ID: 6234269
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of acute urinary infection by norfloxacin or nalidixic acid/citrate: a multi-centre comparative study.
    Reeves DS; Lacey RW; Mummery RV; Mahendra M; Bint AJ; Newsom SW
    J Antimicrob Chemother; 1984 May; 13 Suppl B():99-105. PubMed ID: 6234282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Norfloxacin sensitivity of bacterial pathogens of urinary tract infections].
    Modde H
    Schweiz Rundsch Med Prax; 1985 Apr; 74(17):439-42. PubMed ID: 3159064
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics of norfloxacin in renal failure.
    Fillastre JP; Hannedouche T; Leroy A; Humbert G
    J Antimicrob Chemother; 1984 Oct; 14(4):439. PubMed ID: 6238930
    [No Abstract]   [Full Text] [Related]  

  • 16. Norfloxacin-induced rheumatic disease.
    Bailey RR; Kirk JA; Peddie BA
    N Z Med J; 1983 Jul; 96(736):590. PubMed ID: 6223241
    [No Abstract]   [Full Text] [Related]  

  • 17. Norfloxacin, amoxycillin, cotrimoxazole and nalidixic acid. A summary of 3-day and 7-day therapy studies in the treatment of urinary tract infections.
    Vogel R; Deaney NB; Round EM; VandenBurg MJ; Currie WJ
    J Antimicrob Chemother; 1984 May; 13 Suppl B():113-20. PubMed ID: 6234271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norfloxacin and silver norfloxacin in the treatment of Pseudomonas corneal ulcer in the rabbit.
    Darrell RW; Modak SM; Fox CL
    Trans Am Ophthalmol Soc; 1984; 82():75-91. PubMed ID: 6242083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A controlled trial of norfloxacin and amoxycillin in the treatment of uncomplicated urinary tract infection in the elderly.
    Hill S; Yeates M; Pathy J; Morgan JR
    J Antimicrob Chemother; 1985 Apr; 15(4):505-6. PubMed ID: 3159711
    [No Abstract]   [Full Text] [Related]  

  • 20. Bactericidal effects of norfloxacin towards bacteria in urine.
    Lacey RW; Lord VL; Howson GL
    J Antimicrob Chemother; 1984 May; 13 Suppl B():49-54. PubMed ID: 6234275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.